Q1 FY27 results approved, director changes, subsidiary capital infusion

Going ConcernQualified OpinionAdverse OpinionEmphasis Of MatterPat Growth 25pctExceptional ItemResults View source PDF

3IINFOLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.4%1-day move

₹20.60

prior close

₹20.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1-0.6-0.4-1.4-1.4—————————

Up moveDown movePending

AI summary

Board approved Q1 FY27 results: consolidated revenue Rs 17,794 lakh, PAT Rs 652 lakh vs Rs 455 lakh YoY. Standalone PAT jumped to Rs 660 lakh from Rs 140 lakh. Auditor gave qualified conclusion flagging going-concern at multiple subsidiaries and legacy IPR matters (Rs 1,066 crore unpaid since 2012). Director Ambarish Dasgupta retires; Sanjay Vatsa appointed. Rs 11.11 crore loan to subsidiary NuRe FutureTech converted to preference shares, plus Rs 2 crore fresh infusion.

Likely market impact

Profitability up, but auditor flagged legacy issues and subsidiary going-concern risks. Watch closely.